IN2013DE03040A - - Google Patents

Info

Publication number
IN2013DE03040A
IN2013DE03040A IN3040DE2013A IN2013DE03040A IN 2013DE03040 A IN2013DE03040 A IN 2013DE03040A IN 3040DE2013 A IN3040DE2013 A IN 3040DE2013A IN 2013DE03040 A IN2013DE03040 A IN 2013DE03040A
Authority
IN
India
Prior art keywords
plasminogen
sak
staphylokinase
utilized
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Singh Satish
Bhando Timsy
Lata Dikshit Kanak
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Priority to IN3040DE2013 priority Critical patent/IN2013DE03040A/en
Publication of IN2013DE03040A publication Critical patent/IN2013DE03040A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3040DE2013 2013-10-11 2013-10-11 IN2013DE03040A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3040DE2013 IN2013DE03040A (ko) 2013-10-11 2013-10-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3040DE2013 IN2013DE03040A (ko) 2013-10-11 2013-10-11

Publications (1)

Publication Number Publication Date
IN2013DE03040A true IN2013DE03040A (ko) 2015-04-17

Family

ID=54397091

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3040DE2013 IN2013DE03040A (ko) 2013-10-11 2013-10-11

Country Status (1)

Country Link
IN (1) IN2013DE03040A (ko)

Similar Documents

Publication Publication Date Title
MX2019008803A (es) Anticuerpos contra el inhibidor del activador de plasminogeno tipo 1 (pai-1) y usos de los mismos.
SA518400424B1 (ar) جزيئات الجسم المضاد لعلاج السرطان
MX2018008416A (es) Polipéptidos heterodímericos condicionalmente activos y métodos para su uso.
MY186864A (en) Fusion immunomodulatory proteins and methods for making same
MX2023001119A (es) Variantes de enzimas y polinucleotidos que las codifican.
NZ743008A (en) Compositions and methods for internalizing enzymes
BR112016004095A2 (pt) administração de enzimas de empobrecimento de quinurenina para a terapia contra tumores
MX2015001083A (es) Polipeptidos de factor x modificados y usos de los mismos.
MX2016008631A (es) Proteina heterodimérica il-5 y usos de la misma.
EA201991409A3 (ru) Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения
JO3532B1 (ar) الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
WO2017015622A8 (en) Gdf11 binding proteins and uses thereof
MX2013007791A (es) Variantes de plasminogeno y plasmina.
SG10201906859PA (en) Novel proteins specific for angiogenesis
WO2015031726A3 (en) Engineered primate l-methioninase for therapeutic purposes
EP2575856A4 (en) INNOVATIVE DISCOVERY OF THERAPEUTIC COMPOSITIONS, DIAGNOSTICS AND ANTIBODIES RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-ARNT SYNTHETASES
MX2019014379A (es) Casetes de expresion optimizados del gen del factor de coagulacion ix humano y su uso.
EA201491784A1 (ru) Антитела против лигандов рецептора в1 брадикинина
MX2015006859A (es) Anticuerpos anti-vegf y sus usos.
PH12019501405A1 (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
PH12020550927A1 (en) Therapeutic enzyme fusion protein having novel structure and use thereof
EA201400964A1 (ru) Cx3cr1-связывающие полипептиды
MX2017011794A (es) Composiciones y metodos para diagnosticos y tratamiento del cancer.
NZ612608A (en) Upar-antagonists and uses thereof
PH12019501108A1 (en) Anti-gitr anti-binding protein and methods of use thereof